Citadel Advisors
IBBQ icon

Citadel Advisors’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Citadel Advisors’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,709
Closed -$230K – 14953
2024
Q4 		$230K Sell
10,709
-2,574
-19% -$59.4K ﹤0.01% 10183
2024
Q3 		$316K Buy
+13,283
New +$317K ﹤0.01% 9225
2023
Q4 		– Sell
-18,554
Closed -$368K – 14716
2023
Q3 		$368K Buy
+18,554
New +$379K ﹤0.01% 8726
2023
Q2 		– Sell
-15,337
Closed -$317K – 14739
2023
Q1 		$317K Buy
+15,337
New +$321K ﹤0.01% 9270

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's IBBQ Position: Q1 2025 in Review

Citadel Advisors sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2025, closing a stake of 10,709 shares — an estimated $230K sold.

Citadel Advisors first reported a position in IBBQ in Q1 2023 and held it in 4 quarters. The position peaked at $368K in Q3 2023. 18 funds tracked by Wall St. Rank hold IBBQ as of Q1 2025.

  • Citadel Advisors reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,709 Invesco NASDAQ Biotechnology ETF shares in Q1 2025, an estimated $230K.
  • Citadel Advisors first reported a position in Invesco NASDAQ Biotechnology ETF in Q1 2023 and held it in 4 quarters.
  • Citadel Advisors's Invesco NASDAQ Biotechnology ETF position peaked at $368K in Q3 2023.
  • 18 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.